MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.

MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.
复制标题

DOI:
10.1186/1477-7819-12-195
复制
发表时间:
2014-06-27
影响因子:
3.2
通讯作者:
Wu ZH
Wu ZH
中科院分区:
医学3区
文献类型:
--
作者:
Xu SH;Yang YL;Han SM;Wu ZH

文献摘要

参考文献

被引文献

相似文献

本研究旨在检测骨肉瘤组织和正常骨组织中微小RNA-9(miR-9)的表达水平,探讨miR-9表达与骨肉瘤患者临床病理特征及预后的关系。采用实时定量分析检测骨肉瘤组织和相应非癌组织中miR-9的表达水平。使用 Kaplan-Meier 方法和对数秩检验确定患者生存率的差异。 Cox比例风险回归分析用于预后值的单变量和多变量分析。与非癌性骨组织相比,骨肉瘤组织中miR-9的表达水平显着升高(P<0.001)。我们发现miR-9的表达水平与肿瘤大小(P = 0.011)、临床分期(P = 0.009)和远处转移(P < 0.001)显着相关。 Kaplan-Meier曲线显示,miR-9低表达患者的生存期明显长于miR-9高表达患者(P = 0.0017)。多变量分析表明miR-9表达水平(P = 0.002)是总体生存的独立预后因素。我们的研究结果表明,miR-9表达增加与骨肉瘤的侵袭性进展有很强的相关性,其过度表达是影响总体生存的统计学上显着的危险因素,这表明miR-9表达增加可能是肿瘤进展和骨肉瘤预后的有价值的标志物。
The purpose of the present study was to examine the expression levels of microRNA-9 (miR-9) in osteosarcoma tissues and normal bone tissues, and investigate the relationships between miR-9 expression, clinicopathological features and the prognosis of patients with osteosarcoma. The expression levels of miR-9 in osteosarcoma tissues and corresponding non-cancerous tissues were detected using a real-time quantitative assay. Differences in patient survival were determined using the Kaplan–Meier method and a log-rank test. A Cox proportional hazards regression analysis was used for univariate and multivariate analyses of prognostic values. Compared to non-cancerous bone tissues, the expression levels of miR-9 in osteosarcoma tissues were significantly elevated (P < 0.001). We found that the expression level of miR-9 was significantly associated with tumor size (P = 0.011), clinical stage (P = 0.009) and distant metastasis (P < 0.001). The Kaplan–Meier curve showed that patients with low miR-9 expression survived significantly longer than patients with high miR-9 expression (P = 0.0017). Multivariate analysis suggested that miR-9 expression level (P = 0.002) is an independent prognostic factors for overall survival. The findings of our study suggest that increased miR-9 expression has a strong correlation with the aggressive progression of osteosarcoma and its overexpression is a statistically significant risk factor affecting overall survival, suggesting that increased miR-9 expression could be a valuable marker of tumor progression and for prognosis of osteosarcoma.
DOI: 10.3892/ol.2012.866
发表时间: 2012-11-01
期刊: ONCOLOGY LETTERS
影响因子: 2.9
作者:
Hu, Hao;Zhang, Yi;Cai, Lin
通讯作者: Cai, Lin
DOI: 10.1371/journal.pone.0055719
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者:
Zheng L;Qi T;Yang D;Qi M;Li D;Xiang X;Huang K;Tong Q
通讯作者: Tong Q
DOI: 10.1111/j.1750-3639.2008.00184.x
发表时间: 2009-07
期刊: Brain pathology (Zurich, Switzerland)
影响因子: --
作者:
Nass D;Rosenwald S;Meiri E;Gilad S;Tabibian-Keissar H;Schlosberg A;Kuker H;Sion-Vardy N;Tobar A;Kharenko O;Sitbon E;Lithwick Yanai G;Elyakim E;Cholakh H;Gibori H;Spector Y;Bentwich Z;Barshack I;Rosenfeld N
通讯作者: Rosenfeld N
DOI: 10.1371/journal.pone.0039011
发表时间: 2012
期刊: PloS one
影响因子: 3.7
作者:
Zhou X;Marian C;Makambi KH;Kosti O;Kallakury BV;Loffredo CA;Zheng YL
通讯作者: Zheng YL
DOI: 10.1038/onc.2010.305
发表时间: 2010-10-01
期刊: ONCOGENE
影响因子: 8
作者:
Hildebrandt, M. A. T.;Gu, J.;Wu, X.
通讯作者: Wu, X.